July 25, 2016 1:41 PM ET

Pharmaceuticals

Company Overview of PanGenetics B.V.

Company Overview

PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases, cancer, and pain. The company develops a portfolio of antibody drugs through in-licensing model. Its products pipeline includes PG102-Prototype, an original chimeric anti-CD40 antibody; PG102, a CD40 antagonist; PG110, an anti-nerve growth factor antibody for use in chronic pain; PG130, an undisclosed therapeutic antibody; and PG140, an antagonist of CD86. PanGenetics B.V. was formerly known as Tanox Pharma B.V. The company was founded in 1995 and is based in Utrecht, the Netherlands. The company has an additional office in Cambridge, United Kingdom. PanGenetics B.V. is a former subsidiary of Tanox...

Yalelaan 46

Utrecht,  3584CM

Netherlands

Founded in 1995

Phone:

31 30 253 7911

Fax:

31 30 253 3967

Key Executives for PanGenetics B.V.

PanGenetics B.V. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
All-Gen Pharmaceuticals and Generics B.V. Europe
Alzheimer Research Centrum BV Europe
Angita B.V. Europe
AquaCultura B.V. Europe
Arcarios B.V. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PanGenetics B.V., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.